Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 5822 entries
Sorted by: Best Match Show Resources per page
Type II diabetes and its complications in Mexican Americans.

Diabetes/metabolism reviews

Stern MP, Haffner SM.
PMID: 2192854
Diabetes Metab Rev. 1990 Feb;6(1):29-45. doi: 10.1002/dmr.5610060102.

The prevalence and incidence of type II diabetes are substantially higher in Mexican Americans than in non-Hispanic whites. This, combined with its earlier age of onset and the younger age structure of the Mexican American population, makes diabetes a...

Cite
Stern MP, Haffner SM. Type II diabetes and its complications in Mexican Americans. Diabetes Metab Rev. 1990;6(1):29-45doi: 10.1002/dmr.5610060102.
Stern, M. P., & Haffner, S. M. (1990). Type II diabetes and its complications in Mexican Americans. Diabetes/metabolism reviews, 6(1), 29-45. https://doi.org/10.1002/dmr.5610060102
Stern, M P, and Haffner, S M. "Type II diabetes and its complications in Mexican Americans." Diabetes/metabolism reviews vol. 6,1 (1990): 29-45. doi: https://doi.org/10.1002/dmr.5610060102
Stern MP, Haffner SM. Type II diabetes and its complications in Mexican Americans. Diabetes Metab Rev. 1990 Feb;6(1):29-45. doi: 10.1002/dmr.5610060102. PMID: 2192854.
Copy Download .nbib Format: NLM
Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment.

Diabetes, metabolic syndrome and obesity : targets and therapy

Scott D.
PMID: 24124385
Diabetes Metab Syndr Obes. 2013 Oct 02;6:359-63. doi: 10.2147/DMSO.S51795. eCollection 2013.

Diabetes is the leading cause of chronic kidney disease, and the prevalence of both diseases is rising worldwide. Treatment of type 2 diabetes is difficult in patients with chronic kidney disease because most oral antidiabetic agents are affected by...

Cite
Scott D. Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment. Diabetes Metab Syndr Obes. 2013;6:359-63doi: 10.2147/DMSO.S51795.
Scott, D. (2013). Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment. Diabetes, metabolic syndrome and obesity : targets and therapy, 6359-63. https://doi.org/10.2147/DMSO.S51795
Scott, David. "Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 6 (2013): 359-63. doi: https://doi.org/10.2147/DMSO.S51795
Scott D. Treatment of type 2 diabetes in chronic kidney disease: a case for linagliptin in the treatment of diabetes in severe renal impairment. Diabetes Metab Syndr Obes. 2013 Oct 02;6:359-63. doi: 10.2147/DMSO.S51795. eCollection 2013. PMID: 24124385; PMCID: PMC3795009.
Copy Download .nbib Format: NLM
Type 2 Diabetes Genetics: Beyond GWAS.

Journal of diabetes & metabolism

Sanghera DK, Blackett PR.
PMID: 23243555
J Diabetes Metab. 2012 Jun 23;3(198). doi: 10.4172/2155-6156.1000198.

The global epidemic of type 2 diabetes mellitus (T2D) is one of the most challenging problems of the 21(st) century leading cause of and the fifth death worldwide. Substantial evidence suggests that T2D is a multifactorial disease with a...

Cite
Sanghera DK, Blackett PR. Type 2 Diabetes Genetics: Beyond GWAS. J Diabetes Metab. 2012;3(198)doi: 10.4172/2155-6156.1000198.
Sanghera, D. K., & Blackett, P. R. (2012). Type 2 Diabetes Genetics: Beyond GWAS. Journal of diabetes & metabolism, 3(198), . https://doi.org/10.4172/2155-6156.1000198
Sanghera, Dharambir K, and Blackett, Piers R. "Type 2 Diabetes Genetics: Beyond GWAS." Journal of diabetes & metabolism vol. 3,198 (2012). doi: https://doi.org/10.4172/2155-6156.1000198
Sanghera DK, Blackett PR. Type 2 Diabetes Genetics: Beyond GWAS. J Diabetes Metab. 2012 Jun 23;3(198). doi: 10.4172/2155-6156.1000198. PMID: 23243555; PMCID: PMC3521576.
Copy Download .nbib Format: NLM
Comparative effectiveness of liraglutide in the treatment of type 2 diabetes.

Diabetes, metabolic syndrome and obesity : targets and therapy

Rigato M, Fadini GP.
PMID: 24672252
Diabetes Metab Syndr Obes. 2014 Mar 18;7:107-20. doi: 10.2147/DMSO.S37644. eCollection 2014.

Type 2 diabetes is characterized by a progressive decline in beta cell function, with consequent worsening of glycemic control. The ideal antihyperglycemic treatment should achieve good and sustained glycemic control, with a low risk of hypoglycemia and no weight...

Cite
Rigato M, Fadini GP. Comparative effectiveness of liraglutide in the treatment of type 2 diabetes. Diabetes Metab Syndr Obes. 2014;7:107-20doi: 10.2147/DMSO.S37644.
Rigato, M., & Fadini, G. P. (2014). Comparative effectiveness of liraglutide in the treatment of type 2 diabetes. Diabetes, metabolic syndrome and obesity : targets and therapy, 7107-20. https://doi.org/10.2147/DMSO.S37644
Rigato, Mauro, and Fadini, Gian Paolo. "Comparative effectiveness of liraglutide in the treatment of type 2 diabetes." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 7 (2014): 107-20. doi: https://doi.org/10.2147/DMSO.S37644
Rigato M, Fadini GP. Comparative effectiveness of liraglutide in the treatment of type 2 diabetes. Diabetes Metab Syndr Obes. 2014 Mar 18;7:107-20. doi: 10.2147/DMSO.S37644. eCollection 2014. PMID: 24672252; PMCID: PMC3964023.
Copy Download .nbib Format: NLM
A rare cause of metabolic acidosis: ketoacidosis in a non-diabetic lactating woman.

Endocrinology, diabetes & metabolism case reports

Sloan G, Ali A, Webster J.
PMID: 28924478
Endocrinol Diabetes Metab Case Rep. 2017 Sep 04;2017. doi: 10.1530/EDM-17-0073. eCollection 2017.

Ketoacidosis occurring during lactation has been described infrequently. The condition is incompletely understood, but it appears to be associated with a combination of increased metabolic demands during lactation, reduction in carbohydrate intake and acute illness. We present a case...

Cite
Sloan G, Ali A, Webster J. A rare cause of metabolic acidosis: ketoacidosis in a non-diabetic lactating woman. Endocrinol Diabetes Metab Case Rep. 2017;2017doi: 10.1530/EDM-17-0073.
Sloan, G., Ali, A., & Webster, J. (2017). A rare cause of metabolic acidosis: ketoacidosis in a non-diabetic lactating woman. Endocrinology, diabetes & metabolism case reports, 2017. https://doi.org/10.1530/EDM-17-0073
Sloan, Gordon, et al. "A rare cause of metabolic acidosis: ketoacidosis in a non-diabetic lactating woman." Endocrinology, diabetes & metabolism case reports vol. 2017 (2017). doi: https://doi.org/10.1530/EDM-17-0073
Sloan G, Ali A, Webster J. A rare cause of metabolic acidosis: ketoacidosis in a non-diabetic lactating woman. Endocrinol Diabetes Metab Case Rep. 2017 Sep 04;2017. doi: 10.1530/EDM-17-0073. eCollection 2017. PMID: 28924478; PMCID: PMC5592701.
Copy Download .nbib Format: NLM
Peripheral Sensory Neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia.

Journal of diabetes and metabolic disorders

Jember G, Melsew YA, Fisseha B, Sany K, Gelaw AY, Janakiraman B.
PMID: 28396852
J Diabetes Metab Disord. 2017 Apr 04;16:16. doi: 10.1186/s40200-017-0295-5. eCollection 2017.

BACKGROUND: Diabetic sensory neuropathy is a common form of microvascular complication among diabetic patients. The swiftly growing population of people living with diabetes in Ethiopia and lack of elaborated scientific data on peripheral sensory neuropathy among diabetic population in...

Cite
Jember G, Melsew YA, Fisseha B, et al. Peripheral Sensory Neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia. J Diabetes Metab Disord. 2017;16:16doi: 10.1186/s40200-017-0295-5.
Jember, G., Melsew, Y. A., Fisseha, B., Sany, K., Gelaw, A. Y., & Janakiraman, B. (2017). Peripheral Sensory Neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia. Journal of diabetes and metabolic disorders, 1616. https://doi.org/10.1186/s40200-017-0295-5
Jember, Gashaw, et al. "Peripheral Sensory Neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia." Journal of diabetes and metabolic disorders vol. 16 (2017): 16. doi: https://doi.org/10.1186/s40200-017-0295-5
Jember G, Melsew YA, Fisseha B, Sany K, Gelaw AY, Janakiraman B. Peripheral Sensory Neuropathy and associated factors among adult diabetes mellitus patients in Bahr Dar, Ethiopia. J Diabetes Metab Disord. 2017 Apr 04;16:16. doi: 10.1186/s40200-017-0295-5. eCollection 2017. PMID: 28396852; PMCID: PMC5381058.
Copy Download .nbib Format: NLM
Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes.

Diabetes & metabolism journal

Kim MJ, Koo YD, Kim M, Lim S, Park YJ, Chung SS, Jang HC, Park KS.
PMID: 27535645
Diabetes Metab J. 2016 Oct;40(5):406-413. doi: 10.4093/dmj.2016.40.5.406. Epub 2016 Aug 12.

BACKGROUND: Panax ginseng has glucose-lowering effects, some of which are associated with the improvement in insulin resistance in skeletal muscle. Because mitochondria play a pivotal role in the insulin resistance of skeletal muscle, we investigated the effects of the...

Cite
Kim MJ, Koo YD, Kim M, et al. Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes. Diabetes Metab J. 2016;40(5):406-413doi: 10.4093/dmj.2016.40.5.406.
Kim, M. J., Koo, Y. D., Kim, M., Lim, S., Park, Y. J., Chung, S. S., Jang, H. C., & Park, K. S. (2016). Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes. Diabetes & metabolism journal, 40(5), 406-413. https://doi.org/10.4093/dmj.2016.40.5.406
Kim, Min Joo, et al. "Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes." Diabetes & metabolism journal vol. 40,5 (2016): 406-413. doi: https://doi.org/10.4093/dmj.2016.40.5.406
Kim MJ, Koo YD, Kim M, Lim S, Park YJ, Chung SS, Jang HC, Park KS. Rg3 Improves Mitochondrial Function and the Expression of Key Genes Involved in Mitochondrial Biogenesis in C2C12 Myotubes. Diabetes Metab J. 2016 Oct;40(5):406-413. doi: 10.4093/dmj.2016.40.5.406. Epub 2016 Aug 12. PMID: 27535645; PMCID: PMC5069397.
Copy Download .nbib Format: NLM
Exogenous T3 toxicosis following consumption of a contaminated weight loss supplement.

Endocrinology, diabetes & metabolism case reports

D'Arcy R, McDonnell M, Spence K, Courtney CH.
PMID: 28883920
Endocrinol Diabetes Metab Case Rep. 2017 Aug 29;2017. doi: 10.1530/EDM-17-0087. eCollection 2017.

A 42-year-old male presented with a one-week history of palpitations and sweating episodes. The only significant history was of longstanding idiopathic dilated cardiomyopathy. Initial ECG demonstrated a sinus tachycardia. Thyroid function testing, undertaken as part of the diagnostic workup,...

Cite
D'Arcy R, McDonnell M, Spence K, et al. Exogenous T3 toxicosis following consumption of a contaminated weight loss supplement. Endocrinol Diabetes Metab Case Rep. 2017;2017doi: 10.1530/EDM-17-0087.
D'Arcy, R., McDonnell, M., Spence, K., & Courtney, C. H. (2017). Exogenous T3 toxicosis following consumption of a contaminated weight loss supplement. Endocrinology, diabetes & metabolism case reports, 2017. https://doi.org/10.1530/EDM-17-0087
D'Arcy, R, et al. "Exogenous T3 toxicosis following consumption of a contaminated weight loss supplement." Endocrinology, diabetes & metabolism case reports vol. 2017 (2017). doi: https://doi.org/10.1530/EDM-17-0087
D'Arcy R, McDonnell M, Spence K, Courtney CH. Exogenous T3 toxicosis following consumption of a contaminated weight loss supplement. Endocrinol Diabetes Metab Case Rep. 2017 Aug 29;2017. doi: 10.1530/EDM-17-0087. eCollection 2017. PMID: 28883920; PMCID: PMC5581371.
Copy Download .nbib Format: NLM
Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).

Diabetes & metabolism journal

Kong SH, Koo BK, Moon MK.
PMID: 28447443
Diabetes Metab J. 2017 Apr;41(2):152-153. doi: 10.4093/dmj.2017.41.2.152.

No abstract available.

Cite
Kong SH, Koo BK, Moon MK. Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30). Diabetes Metab J. 2017;41(2):152-153doi: 10.4093/dmj.2017.41.2.152.
Kong, S. H., Koo, B. K., & Moon, M. K. (2017). Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30). Diabetes & metabolism journal, 41(2), 152-153. https://doi.org/10.4093/dmj.2017.41.2.152
Kong, Sung Hye, et al. "Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30)." Diabetes & metabolism journal vol. 41,2 (2017): 152-153. doi: https://doi.org/10.4093/dmj.2017.41.2.152
Kong SH, Koo BK, Moon MK. Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30). Diabetes Metab J. 2017 Apr;41(2):152-153. doi: 10.4093/dmj.2017.41.2.152. PMID: 28447443; PMCID: PMC5409003.
Copy Download .nbib Format: NLM
Frequency of Food Consumption and Self-reported Diabetes among Adult Men and Women in India: A Large Scale Nationally Representative Cross-sectional Study.

Journal of diabetes & metabolism

Agrawal S.
PMID: 28856030
J Diabetes Metab. 2015 Jan 02;6(1):474. doi: 10.4172/2155-6156.1000474.

BACKGROUND: Recent studies have shown that the choice of foods and frequency of intake plays a role in diabetes prevention. We examined the association between frequency of consumption of specific food items and the occurrence of diabetes in adult...

Cite
Agrawal S. Frequency of Food Consumption and Self-reported Diabetes among Adult Men and Women in India: A Large Scale Nationally Representative Cross-sectional Study. J Diabetes Metab. 2015;6(1):474doi: 10.4172/2155-6156.1000474.
Agrawal, S. (2015). Frequency of Food Consumption and Self-reported Diabetes among Adult Men and Women in India: A Large Scale Nationally Representative Cross-sectional Study. Journal of diabetes & metabolism, 6(1), 474. https://doi.org/10.4172/2155-6156.1000474
Agrawal, Sutapa. "Frequency of Food Consumption and Self-reported Diabetes among Adult Men and Women in India: A Large Scale Nationally Representative Cross-sectional Study." Journal of diabetes & metabolism vol. 6,1 (2015): 474. doi: https://doi.org/10.4172/2155-6156.1000474
Agrawal S. Frequency of Food Consumption and Self-reported Diabetes among Adult Men and Women in India: A Large Scale Nationally Representative Cross-sectional Study. J Diabetes Metab. 2015 Jan 02;6(1):474. doi: 10.4172/2155-6156.1000474. PMID: 28856030; PMCID: PMC5573179.
Copy Download .nbib Format: NLM
Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine.

Diabetes, metabolic syndrome and obesity : targets and therapy

Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A.
PMID: 26396537
Diabetes Metab Syndr Obes. 2015 Sep 18;8:437-45. doi: 10.2147/DMSO.S69199. eCollection 2015.

BACKGROUND: The aim of this study is to evaluate the impact of coexistence of metabolic syndrome (MS) and type 2 diabetes mellitus (T2DM) on the estimated cardiovascular risk as calculated using the United Kingdom Prospective Diabetic Study risk engine...

Cite
Ogedengbe OS, Ezeani IU, Chukwuonye II, et al. Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine. Diabetes Metab Syndr Obes. 2015;8:437-45doi: 10.2147/DMSO.S69199.
Ogedengbe, O. S., Ezeani, I. U., Chukwuonye, I. I., Anyabolu, E. N., Ozor, I. I., & Eregie, A. (2015). Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine. Diabetes, metabolic syndrome and obesity : targets and therapy, 8437-45. https://doi.org/10.2147/DMSO.S69199
Ogedengbe, O Stephen, et al. "Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine." Diabetes, metabolic syndrome and obesity : targets and therapy vol. 8 (2015): 437-45. doi: https://doi.org/10.2147/DMSO.S69199
Ogedengbe OS, Ezeani IU, Chukwuonye II, Anyabolu EN, Ozor II, Eregie A. Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine. Diabetes Metab Syndr Obes. 2015 Sep 18;8:437-45. doi: 10.2147/DMSO.S69199. eCollection 2015. PMID: 26396537; PMCID: PMC4577267.
Copy Download .nbib Format: NLM
Marked hyperandrogenicity in a 60-year-old woman.

Endocrinology, diabetes & metabolism case reports

Aljenaee K, Ali S, Cheah SK, MacEneaney O, Mulligan N, Hickey N, Tun TK, Sreenan S, McDermott JH.
PMID: 28924479
Endocrinol Diabetes Metab Case Rep. 2017 Sep 04;2017. doi: 10.1530/EDM-17-0075. eCollection 2017.

Markedly elevated androgen levels can lead to clinical virilization in females. Clinical features of virilization in a female patient, in association with biochemical hyperandrogenism, should prompt a search for an androgen-producing tumor, especially of ovarian or adrenal origin. We...

Cite
Aljenaee K, Ali S, Cheah SK, et al. Marked hyperandrogenicity in a 60-year-old woman. Endocrinol Diabetes Metab Case Rep. 2017;2017doi: 10.1530/EDM-17-0075.
Aljenaee, K., Ali, S., Cheah, S. K., MacEneaney, O., Mulligan, N., Hickey, N., Tun, T. K., Sreenan, S., & McDermott, J. H. (2017). Marked hyperandrogenicity in a 60-year-old woman. Endocrinology, diabetes & metabolism case reports, 2017. https://doi.org/10.1530/EDM-17-0075
Aljenaee, Khaled, et al. "Marked hyperandrogenicity in a 60-year-old woman." Endocrinology, diabetes & metabolism case reports vol. 2017 (2017). doi: https://doi.org/10.1530/EDM-17-0075
Aljenaee K, Ali S, Cheah SK, MacEneaney O, Mulligan N, Hickey N, Tun TK, Sreenan S, McDermott JH. Marked hyperandrogenicity in a 60-year-old woman. Endocrinol Diabetes Metab Case Rep. 2017 Sep 04;2017. doi: 10.1530/EDM-17-0075. eCollection 2017. PMID: 28924479; PMCID: PMC5592702.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 5822 entries